Post Operative Hemorrhage Clinical Trial
Official title:
Pilot Study Evaluating the Clinical Performance of the Quantra With the QStat Cartridge at the Point-of-care in Obstetric Patients
NCT number | NCT05875987 |
Other study ID # | HEMCS-044 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 1, 2023 |
Est. completion date | May 10, 2024 |
Verified date | May 2024 |
Source | HemoSonics LLC |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This pilot study will assess the performance of the Quantra System with the QStat Cartridge versus standard of care coagulation testing in bleeding pregnant women at delivery.
Status | Completed |
Enrollment | 50 |
Est. completion date | May 10, 2024 |
Est. primary completion date | March 31, 2024 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Subject is > 18 years. - Subject is pregnant or at least 24 h postpartum - Subject is fluent in English language. - Subject is experiencing significant bleeding resulting in activation of the stage 2 OB hemorrhage protocol as defined by blood loss =1500ml at delivery or within the first 24 hours after delivery, and/or is hemodynamically unstable and/or is experiencing increased abnormal bleeding not responsive to OB stage 1 hemorrhage resuscitation. - Subject or subject's legally authorized representative (LAR) is willing to provide informed consent, either prospectively or by deferred consent. Exclusion Criteria: - Subject is incarcerated at the time of the study. - Subject is currently enrolled in a distinct study that might confound the results of the proposed study - Subject is affected by a condition that, in the opinion of the clinical team, may pose additional risks |
Country | Name | City | State |
---|---|---|---|
United States | Duke University Hospital | Durham | North Carolina |
Lead Sponsor | Collaborator |
---|---|
HemoSonics LLC |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of Quantra Clot Time to laboratory aPTT test results | Coagulation function assessed by Quantra Clot Time (CT, sec) and activated partial thromboplastin (aPTT, sec) test | At the time the OB hemorrhage protocol is activated, anticipated with 24 hours after birth | |
Primary | Comparison of Quantra Fibrinogen Contribution to Clot Stiffness to laboratory coagulation fibrinogen test results | Coagulation function assessed by Quantra Fibrinogen Contribution to Clot Stiffness (FCS, hPa) and Clauss fibrinogen (mg/dL) test | At the time the OB hemorrhage protocol is activated, anticipated with 24 hours after birth | |
Primary | Comparison of Quantra Clot Time to ROTEM delta INTEM CT test results | Coagulation function assessed by Quantra Clot Time (CT, sec) and ROTEM INTEM CT (sec) test | At the time the OB hemorrhage protocol is activated, anticipated with 24 hours after birth | |
Primary | Comparison of Quantra Fibrinogen Contribution to Clot Stiffness to ROTEM delta FIBTEM test results | Coagulation function assessed by Quantra Fibrinogen Contribution to Clot Stiffness (FCS, hPa) and ROTEM FIBTEM (mm) test | At the time the OB hemorrhage protocol is activated, anticipated with 24 hours after birth |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05379530 -
TEG Use in Children Undergoing Procedures With High Anticipated Blood Loss
|
N/A | |
Terminated |
NCT03085394 -
Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery
|
Phase 3 | |
Withdrawn |
NCT04388722 -
Monitoring Noninvasively for Infusion and Transfusion Optimization
|
N/A | |
Completed |
NCT06365242 -
Direct Oral Anticoagulants and Management of Blleding Following Dental Extractions. A Prospective Cohort Study.
|
||
Terminated |
NCT03186157 -
Prevalence of Trephined Syndrome After Decompressive Craniectomy
|
||
Completed |
NCT03444792 -
Mechanical Dilatation of the Cervix at Elective Caesarean Section to Reduce Post-Operative Blood Loss
|
N/A | |
Recruiting |
NCT02733952 -
Intravenous Tranexamic Acid Versus Pericervical Tourniquet To Decrease Blood Loss In Trans-Abdominal Myomectomy
|
Phase 3 | |
Recruiting |
NCT06399445 -
Measurement of Blood Loss in Adenotonsillectomy During General Anesthesia According to the Application of Nondepolarizing Muscle Relaxants
|
Phase 4 |